For decades, clinicians have been aware of the risks associated with the. Recently, three prominent physicians, all intent on minimizing risks associated with the Modified Seldinger Technique, received patents for innovative improvements in over-wire catheterization. Seeing the opportunity, Carrot Capital (headed by David Geliebter) acquired the doctors’ patents and assembled the ACCESS team, most of whom were fresh off their success with Venetec International and its groundbreaking StatLock® technology. Simultaneously, the company moved its headquarters from New York to San Diego. ACCESS completed its first funding round in July 2008 with Carrot Capital and other value-added investors.